City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Amrita Y. Krishnan, MD  
Search results:  9  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-9 Trials Jump to page:

COH Protocol Number: 17209 ClinicalTrials.gov Number: NCT03275103

Principal Investigator: Amrita Krishnan, MD
Sponsor: Industrial

Title:  An Open-Label, Multicenter, Phase I Trial Evaluating the Safety and Pharmacokinetics of Escalating Doses of BFCR4350A in Patients with Relapsed or Refractory Multiple Myeloma

COH Protocol Number: 17138 ClinicalTrials.gov Number: NCT03145181

Principal Investigator: Amrita Krishnan, MD
Sponsor: Industrial

Title:  A Phase 1, First-in-Human, Open-Label, Dose Escalation Study of JNJ-64007957, a Humanized BCMA x CD3 DuoBody® Antibody, in Subjects with Relapsed or Refractory Multiple Myeloma

COH Protocol Number: 16305 ClinicalTrials.gov Number: NCT02954796

Principal Investigator: Amrita Krishnan, MD
Sponsor: Industrial

Title:  Phase 1 Study of SGN-CD352A in Patients with Relapsed or Refractory Multiple Myeloma

COH Protocol Number: 16072

Principal Investigator: Amrita Krishnan, MD
Sponsor: Institutional

Title:  Evaluation of a 3D Culture Model in Multiple Myeloma

COH Protocol Number: 15341 ClinicalTrials.gov Number: NCT02884102

Principal Investigator: Amrita Krishnan, MD
Sponsor: Institutional

Title:  Clinical-Grade Molecular Profiling of Patients with Multiple Myeloma and Related Plasma Cell Malignancies (MMRF-002)

COH Protocol Number: 14304 ClinicalTrials.gov Number: NCT02322320

Principal Investigator: Amrita Krishnan, MD
Sponsor: NCI Approved External Peer Review

Title:  BMT CTN 07LT: Continued, Long-Term Follow–Up and Lenalidomide Maintenance Therapy for Patients Who Have Enrolled on BMT CTN 0702

COH Protocol Number: 14098

Principal Investigator: Amrita Krishnan, MD
Sponsor: Institutional

Title:  Plasma Cell Malignancy Tissue Collection Study

COH Protocol Number: 14017 ClinicalTrials.gov Number: NCT02500849

Principal Investigator: Amrita Krishnan, MD
Sponsor: NCI Approved External Peer Review

Title:  A Pilot Study to Evaluate the Feasibility, Safety and Engraftment of Zinc Finger Nucleases (ZFN) CCR5 Modified CD34+ Hematopoietic Stem/Progenitor Cells (SB-728MR-HSPC) in HIV-1 (R5) Infected Patients

COH Protocol Number: 14004 ClinicalTrials.gov Number: NCT02337985

Principal Investigator: Amrita Krishnan, MD
Sponsor: NCI Approved External Peer Review

Title:  Safety and Feasibility of Stem Cell Gene Transfer Following R-EPOCH for Non-Hodgkin Lymphoma in Aids Patients Using Peripheral Blood Stem/Progenitor Cells Treated with a Lentivirus Vector-Encoding Multiple Anti-HIV RNAs

 
Results per page: 25 50 100 All 1-9 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.